戻る Agenda
LS03: 5 Industry Group Joint Session:New Options in Clinical Trial Operation Model?DCT & Remote Utilization (Part 1)
Session Chair(s)
Hiroshi Matsuzawa, MSC
Senior Clinical Expert, Nippon Chemiphar Co., Ltd., Japan
Toshiharu Sano, RPH
Associate Vice President, MSD, Japan
Speaker(s)
Ai Nakamura
Performance Working Group Member, R&D Head Club, Japan
Takeshi Hashimoto, MPHARM
Co-leader, Novartis Pharma K.K., Japan
Masahito Yamanaka
Taskforce Member, EFPIA (Bayer Yakuhin, Ltd.), Japan
Junichi Tanokashira
Clinical Evaluation Expert Committee, Drug Evaluation Committee, Japan Pharmaceutical Manufacturers Association (JPMA), Japan